BenzingaOctober 22, 2026 at 6:56 AM NY5 Days Ago
Argus Research Reiterates Buy on Zimmer Biomet Holdings, Maintains $125 Price Target
Argus Research analyst David Toung reiterates Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and maintains $125 price target.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
